In Alzheimer’s disease, TREML2 knockdown suppresses neuroinflammation by inhibiting NLRP3 inflammasome activation and inducing M2 microglial polarization in primary microglia (Wang et al. 2023b). Here, NLRP3 is linked to early-onset autosomal dominant Alzheimer disease.